Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Gahanna, Ohio Clinical Trials

A listing of Gahanna, Ohio clinical trials actively recruiting patient volunteers.

RESULTS

Found (11) clinical trials

Cystogram Before Removal of Foley Catheter After Repair of Colovesical Fistula

Colovesical fistulas are well-recognized but relatively uncommon pathology to both the general and colorectal surgeon. It is a complication arising from an underlying primary acute to chronic inflammatory process. Although colovesical fistulas are uncommon, they are associated with significant morbidity, affect quality of life, and may lead to death, usually ...

Phase N/A

3.29 miles

Learn More »

: A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men ( TRAVERSE )

This is a blinded and placebo-controlled study of topical testosterone replacement therapy (TRT) in symptomatic hypogonadal men with increased risk for cardiovascular (CV) disease.

Phase

4.05 miles

Learn More »

A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults

The study will describe the safety, tolerability, and immunogenicity of up to 6 RSV vaccine formulations when administered alone or concomitantly with SIIV. Healthy male and female subjects divided into 2 age groups (18-49 years of age and 50-85 years of age in the sentinel cohort and 18-49 years of ...

Phase

4.05 miles

Learn More »

Phase I/IIa Trial Evaluating scAAV1.tMCK.NTF3 for Treatment of CMT1A

This clinical trial is an open-label, one-time injection ascending dose study in which scAAV1.tMCK.NTF3 will be administered by intramuscular injections into medial and lateral heads of gastrocnemius and tibialis anterior muscles in both legs in CMT1A subjects with PMP22 gene duplication. Nine CMT1A patients, 15 to 35 years of age ...

Phase

6.23 miles

Learn More »

Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis

This Phase 1/2, first-in-human study will evaluate the safety and tolerability of single and multiple escalating doses of MRT5005 administered by nebulization to the respiratory tract of adult subjects with CF. This study will also assess the delivery of the drug to bronchial epithelial cells following multiple doses of MRT5005, ...

Phase

6.23 miles

Learn More »

Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease

A series of N-of-1 trials will be used to determine the effectiveness of a specific carbohydrate diet (SCD) versus a modified SCD in patients in reducing symptoms and inflammatory burden at both the individual and population level. This is a three-year study. The study staff will recruit 120 patients (goal ...

Phase N/A

6.23 miles

Learn More »

CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes

Eligible subjects who have been prescribed and chronically taking a commercially approved CFTR modulator for at least 3 months will be enrolled for a single visit to collect sweat to be analyzed for SC at their local site laboratory. Limited clinical data obtained at this visit will be augmented by ...

Phase N/A

6.23 miles

Learn More »

Nonarthritic Hip Disease Evaluation And Treatment

The clinical evaluation by the physician is standard-of-care and performed as part of potential participants' scheduled appointment. Participants in this study will complete a HIPAA authorization to allow data from their clinical evaluation by the physician to be utilized for this study, including any imaging the physician used in their ...

Phase N/A

7.01 miles

Learn More »

Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma

The study will consist of 4 phases: a screening, an induction, randomization and follow-up phase. Screening phase: Screening assessments will be conducted within 28 days prior to initiation of Induction Phase treatment to determine each patient's overall eligibility. These assessments will include medical history; physical examination; Eastern Cooperative Oncology Group ...

Phase

7.34 miles

Learn More »

An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma

NOTE: Currently, this study is only open to nivolumab+daratumumab vs daratumumab monotherapy in multiple myeloma patients.

Phase

7.34 miles

Learn More »